Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 241 results
A custom DNA strand on a lab bench with a pipette nearby.

Nov 4, 2026

Building Custom DNA without Bacterial Constraints

Ribbon Bio is revolutionizing DNA assembly by eliminating the reliance on bacterial hosts, addressing significant challenges faced by molecular biologists.Traditionally, constructing custom DNA sequences involves inserting them into bacteria, a method that has been the cornerstone of molecular biology for decades. However, this approach is often slow, requires extensive infrastructure, and can fail with certain sequences that bacteria struggle to maintain. Ribbon Bio's innovative cell-free assem
Press release cover image

Nov 4, 2026

MyOme and SickKids Collaborate to Clinically Validate DNA Methylation Signatures Using Long-Read Sequencing

MyOme Licenses SickKids-Developed DNA Methylation Signatures to Strengthen Long-Read Rare Disease Testing.MENLO PARK, Calif., Nov. 4, 2026 /PRNewswire/ -- MyOme, a CLIA-certified, CAP-accredited clinical whole-genome analysis company, today announced a licensing and research agreement with The Hospital for Sick Children (SickKids) through its Industry Partnerships & Commercialization (IP&C) team under which MyOme will integrate DNA methylation signatures developed by SickKids researchers
Press release cover image

Nov 4, 2026

Immunocan Achieves Megabase-Scale Human Immunoglobulin Gene Replacement in Rabbits, Creating a Cross-Species Data Engine for AI-Driven Antibody Discovery

SHANGHAI--(BUSINESS WIRE)--Shanghai Immunocan Biotech Co., Ltd. (“Immunocan”) today announced the successful in situ replacement of megabase (Mb)-scale human immunoglobulin (Ig) gene segments at endogenous Ig loci in rabbits using its proprietary MASIRT® (Massive-fragment Across Species In situ Replacement Technology) platform.Genotypic characterization confirmed targeted, single-step replacement with the human sequences. Unlike conventional transgenic approaches that often rely on random integr
Press release cover image

Nov 4, 2026

Circular Genomics and PharmatrophiX Announce Strategic Collaboration to Advance circRNA Biomarkers in Neurodegenerative Drug Development

Collaboration will initially apply blood-based circular RNA profiling to LM11A-31 in Alzheimer's disease, with potential expansion across PharmatrophiX's neurodegeneration pipelineSAN DIEGO and MENLO PARK, Calif., Nov. 4, 2026 /PRNewswire/ -- Circular Genomics, Inc., a precision neurology company developing circular RNA (circRNA)-based biomarkers, and PharmatrophiX, Inc., a clinical-stage biopharmaceutical company developing disease-modifying therapies for neurodegenerative diseases, today annou
Press release cover image

Nov 4, 2026

Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine

Alamar’s NULISAseq™ Immune 340 and NULISAseq™ Neuro 220 panels will be used to investigate disease progression, biological subtypes and treatment responseFREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced a strategic scientific collaboration with GSK plc (LSE/NYSE: GSK)  that will use Alamar’s NULISA™ platform in a large-scale study examining how ci
Press release cover image

Nov 3, 2026

Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery

Adds MOBILion's breakthrough SLIM high-resolution ion mobility technology, which separates molecules by size, shape and charge in milliseconds, complementing Waters' industry leading mass spectrometry platform, transforming samples to insights.Accelerates Waters' move into proteomics with research capabilities built for AI foundation and frontier models, pairing the unique speed and resolution of the Xevo™ MRT MS with data generation at the scale needed to power proteomics lab-in-the-loop resear
A flat illustration of a DNA strand representing human genetic diversity.

Nov 3, 2026

Quantifying the Average Human Genome

Recent research from Exeter University sheds light on the variability of human genomes, revealing that deviation from the reference genome is not only common but expected. This study, which analyzed over 900,000 sequenced genomes, aims to establish a clearer baseline for what constitutes a "normal" human genome.The study highlights that individuals typically differ from the reference genome by approximately 4.4 to 5.2 million positions, depending on their population group. This finding challenge
Press release cover image

Nov 2, 2026

10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium Analysis

Powered by Anthropic's Claude, Sentira Single Cell enables researchers to analyze Chromium data using natural language, accelerating the path from scientific questions to experimental conclusionsPLEASANTON, Calif., Nov. 2, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the commercial launch of Sentira Single Cell, a cloud-based agentic analysis application that puts sophisticate
Press release cover image

Nov 2, 2026

Glioblastoma Foundation's Genomic Testing & Research Laboratory Now Accepting Patient Samples for Genomic Testing

The Foundation's CLIA-certified laboratory combines DNA methylation profiling, MGMT status, copy-number variation analysis and glioblastoma subtype characterization in a single assay DURHAM, NC / ACCESS Newswire / October 31, 2026 / Gliolab, the Glioblastoma Foundation's new CLIA-certified Genomic Testing & Research Laboratory, today announced that it is accepting patient tumor samples for Whole-Genome DNA Methylation Profiling using the Epignostix Classifier, expanding access to one of the
A minimalist representation of an immune cell and RNA-seq profile in a dark color scheme.

Oct 30, 2026

100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic

Parse Biosciences and Nomic Bio have partnered to create Cascade, an extensive dataset aimed at enhancing understanding of the human immune response through a combination of single-cell and proteomic data.The Cascade dataset, consisting of 100 million single-cell RNA-seq profiles and over 11,000 proteomic secretome profiles, aims to provide pharmaceutical companies with a comprehensive view of immune biology. This multimodal dataset captures the responses of various immune cell types to more tha
Press release cover image

Oct 29, 2026

A tiny fish provides big answers: the first full-body map of gene activity in an adult vertebrate

Whitehead Institute researchers have used a recently-discovered tiny, transparent fish species to create the first comprehensive whole-body single-cell atlas of an adult vertebrate. This offers a new resource for studying brain regeneration, cellular diversity, and how different tissues function together.CAMBRIDGE, Mass., Oct. 29, 2026 /PRNewswire/ -- Viewed from above, Danionella cerebrum offers a rare sight in a vertebrate: its brain, visible through the top of its head. Since the species was
Press release cover image

Oct 29, 2026

Arima Genomics Study Shows Hi-C Reveals Clinically Important Rearrangements Beyond Routine FISH

Findings highlight the value of broad structural profiling when targeted testing leaves important questions unresolvedCARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer diagnosis and therapy selection, today announced results from a study conducted with Duke University and recently published in Blood Advances. The study demonstrated the value of broad structural rearrangement profiling in diffuse la